Pura Vida Investments, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Pura Vida Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$2.97 - $5.08 $2.35 Million - $4.01 Million	-789,603 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.48 - $5.05 $2.29 Million - $3.32 Million	-657,350 Reduced 45.43%	789,603 $3.65 Million
Q1 2020 May 15, 2020	BUY	$2.61 - $5.21 $3.78 Million - $7.54 Million	1,446,953 New	1,446,953 $5.57 Million
Q2 2019 Aug 14, 2019	SELL	$2.7 - $6.11 $533,503 - $1.21 Million	-197,594 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$2.11 - $5.33 $36,705 - $92,720	17,396 Added 9.65%	197,594 $1.01 Million
Q4 2018 Feb 14, 2019	SELL	$1.92 - $3.62 $42,798 - $80,693	-22,291 Reduced 11.01%	180,198 $346,000
Q3 2018 Nov 14, 2018	BUY	$2.81 - $3.78 $147,494 - $198,408	52,489 Added 34.99%	202,489 $765,000
Q2 2018 Aug 14, 2018	BUY	$2.26 - $3.84 $338,999 - $576,000	150,000 New	150,000 $468,000

332

94.7M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.46B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.